Sucampo Pharmaceuticals Inc (SCMP) financial statements (2021 and earlier)

Company profile

Business Address 805 KING FARM BOULEVARD, SUITE 550
ROCKVILLE, MD 20850
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments198108946058
Cash and cash equivalents198108724452
Short-term investments  22166
Restricted cash and investments0550  
Receivables69462451
Inventory, net of allowances, customer advances and progress billings2333 0
Inventory2333 0 
Deferred costs00011
Prepaid expense and other current assets2
Deferred tax assets  02 
Other undisclosed current assets16934531
Total current assets:30725112211393
Noncurrent Assets
Inventory, Noncurrent    0
Property, plant and equipment66112
Long-term investments and receivables5 14714
Long-term investments5 14714
Intangible assets, net (including goodwill)201197067
Goodwill7361   
Intangible assets, net (excluding goodwill)128136067
Restricted cash and investments  224
Deferred costs01255
Other noncurrent assets1101
Prepaid expense and other noncurrent assets1
Deferred tax assets, net  11 
Other undisclosed noncurrent assets    2
Total noncurrent assets:214206192435
TOTAL ASSETS:521457142137128
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2929171717
Accounts payable911485
Accrued liabilities12118611
Employee-related liabilities  331
Taxes payable77110
Debt 3982719
Deferred revenue and credits11214
Other liabilities214401
Other undisclosed current liabilities 63(3)(1)
Total current liabilities:3288344340
Noncurrent Liabilities
Long-term debt and lease obligation291213182634
Long-term debt, excluding current maturities291213182634
Liabilities, other than long-term debt316991111
Deferred revenue and credits11578
Deferred tax liabilities, net2152123
Liability, pension and other postretirement and postemployment benefits  1
Other liabilities916221
Other undisclosed noncurrent liabilities  (1)(1)(0)
Total noncurrent liabilities:321283253645
Total liabilities:354371597985
Stockholders' equity
Stockholders' equity attributable to parent, including:16786825843
Treasury stock, value(46)(46)(2)(2)(2)
Additional paid in capital12099847263
Accumulated other comprehensive income5513141616
Retained earnings (accumulated deficit)3820(14)(28)(34)
Other undisclosed stockholders' equity attributable to parent00000
Total stockholders' equity:16786825843
TOTAL LIABILITIES AND EQUITY:521457142137128

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues2301531159081
Revenue, net2171431056957
Cost of revenue(83)(37)(16)(12)(3)
Cost of goods and services sold(76)(37)(16)(12)(3)
Gross profit:147116997778
Operating expenses(93)(72)(73)(69)(72)
Other operating income (expense), net  4545(47)
Other undisclosed operating income (loss)  (44)(43)49
Operating income:54442798
Nonoperating income (expense)(40)(1)(0)1(1)
Investment income, nonoperating00000
Foreign currency transaction gain, before tax  1  
Other nonoperating income (expense)(2)6132
Interest and debt expense(14)(7)(2)(2)(2)
Other undisclosed income from continuing operations before equity method investments, income taxes147222
Income from continuing operations before income taxes:144427108
Income tax expense (benefit)4(10)(14)(4)(3)
Net income available to common stockholders, basic:18331365
Interest on convertible debt0    
Net income available to common stockholders, diluted:19331365

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income:18331365
Other comprehensive income (loss) (0)1  
Comprehensive income:18331465
Other undisclosed comprehensive income (loss), net of tax, attributable to parent41(1)(2)(1)(2)
Comprehensive income, net of tax, attributable to parent:60331263

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: